Kamada Ltd. Banner Image

Kamada Ltd. has reached its limit for free report views

Work for Kamada Ltd.? Upgrade Your Profile and unlock all your annual reports.

Kamada Ltd.

  • Ticker KMDA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kamada Ltd. Logo Image
  • 201-500 Employees
  • Based in Rehovot, Israel
Kamada Ltd. (“the Company”) is a commercial stage plasma-derived biopharmaceutical company focused on orphan indications, with an existing marketed product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purifiedMore, liquid form, as well as other plasma-derived immune globulins. The Company’s flagship product is GLASSIA®, the first liquid, ready-to-use, intravenous plasma-derived AAT product approved by the U.S. FDA. The Company markets GLASSIA in the U.S. through a strategic partnership with Takeda Pharmaceuticals Company Limited and in other countries through local distributors.
Kamada Ltd.

Most Recent Annual Report

Kamada Ltd. MOST RECENT 2019 Annual Report

Report Locked. Kamada Ltd. has reached its limit for free report views.

Older/Archived Annual Reports